Table TDI-10. New clients entering outpatient treatment: age and primary drug at treatment in 2004 for those countries supplying data – Part (viii) Number of clients using volatile inhalants as primary drug

Country

<15

15-19

20-24

25-29

30-34

35-39

40-44

45+

Age known

Age not known

Total

Czech Republic

0

28

5

0

0

0

0

0

33

0

33

Denmark

0

0

0

0

0

0

0

0

0

0

0

Germany

3

6

1

0

0

0

0

0

10

0

10

Greece

0

2

0

0

0

0

0

0

2

0

2

Italy

0

23

67

27

15

6

5

0

143

0

143

Cyprus

0

0

0

0

0

0

0

0

0

0

0

Latvia

17

6

1

0

0

0

0

 

24

0

0

Hungary

9

14

7

2

1

1

0

0

34

0

34

Malta

0

0

0

0

0

0

0

0

0

0

0

Netherlands

0

2

0

0

0

1

0

0

3

0

3

Slovenia

0

0

0

0

0

0

0

0

0

0

0

Slovakia

11

17

12

2

0

0

0

1

43

0

42

Finland

1

1

0

0

0

0

0

0

2

0

2

Sweden

1

2

0

0

0

1

0

0

4

0

4

United Kingdom

92

70

14

11

12

7

3

2

211

0

211

Bulgaria

0

1

1

0

0

0

0

0

2

0

2

 

 

 

 

 

 

 

 

 

 

 

 

Total

134

172

108

42

28

16

8

3

511

0

486

Notes:

Data for Malta refer to outpatient and inpatient treatment centres

See also 'General notes for interpreting data' on the Explanatory notes and help page.

Source: 

2005 Reitox national reports - Table TDI outpatient treatment centres

Data filter | tditab10h-en.xml